Search results
Author(s):
Akshay S Desai
Added:
1 year ago
HFSA 24 - Dr Akshay Desai (Brigham and Women’s Hospital, US) sits down with us to discuss the findings from FINEARTS-HF across the ejection fraction spectrum in heart failure with mildly reduced and preserved ejection fraction.Interview Questions:1. What was the reasoning behind this study? What was the study design and patient population?2. What was the study design and patient population?3…
View more
ARNI for Optimising HFrEF Management
Author(s):
Massimo Iacoviello
,
Filippo M Sarullo
,
Claudio Bilato
,
et al
Added:
7 months ago
Expert Opinion
VAC in HFpEF: Trends and Challenges
Author(s):
Tianzong Li
,
Yiran Luo
,
Lina Zhao
,
et al
Added:
3 months ago
Review Article
New Insights on HFpEF Treatment
Author(s):
Giulio Balestrieri
,
Raul Limonta
,
Enrico Ponti
,
et al
Added:
1 year ago
Review Article
Reverse Remodelling in HFrEF
Author(s):
Silas Ramos Furquim
,
Maria Tereza Sampaio de Sousa Lira
,
Deborah de Sá Pereira Belfort
,
et al
Added:
2 months ago
Review Article
Author(s):
Nicolas Girerd
Added:
9 months ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
AUTHOR: Yazmin SadikNew findings from the DIGIT-HF trial indicate that adding low-dose digitoxin to guideline-directed medical therapy (GDMT) can reduce the risk of hospitalisation and all-cause mortality in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).¹The results were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously…
View more
Benefits of Spironolactone: Win Ratio Analysis of the TOPCAT Trial
Author(s):
Dung Viet Nguyen
,
Hoai Thi Thu Nguyen
Added:
4 months ago
Original Research
Author(s):
Michael R Zile
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
GLP-1RA in Different HFpEF Phenotypes
Author(s):
Aleksandra Bykova
,
Maria Serova
,
Maria Chashkina
,
et al
Added:
1 year ago
Review Article
